5.26
前日終値:
$5.35
開ける:
$5.24
24時間の取引高:
11.97M
Relative Volume:
2.03
時価総額:
$933.51M
収益:
$2.54B
当期純損益:
$-207.36M
株価収益率:
-4.4202
EPS:
-1.19
ネットキャッシュフロー:
$151.25M
1週間 パフォーマンス:
+10.97%
1か月 パフォーマンス:
-11.00%
6か月 パフォーマンス:
-32.04%
1年 パフォーマンス:
-44.63%
Teladoc Health Inc Stock (TDOC) Company Profile
Compare TDOC vs VEEV, TEM, BTSG, HQY, WAY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TDOC
Teladoc Health Inc
|
5.26 | 949.48M | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
182.01 | 30.06B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.25 | 9.91B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
41.43 | 7.24B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.49 | 6.61B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
25.65 | 4.99B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Equal Weight |
| 2025-11-13 | 開始されました | BMO Capital Markets | Market Perform |
| 2025-07-25 | 開始されました | Mizuho | Neutral |
| 2024-11-15 | 開始されました | Goldman | Buy |
| 2024-09-17 | 繰り返されました | Jefferies | Hold |
| 2024-02-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-01-17 | ダウングレード | DA Davidson | Buy → Neutral |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-04-12 | 開始されました | Stephens | Equal-Weight |
| 2023-02-23 | アップグレード | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | アップグレード | Guggenheim | Sell → Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-08-17 | ダウングレード | Guggenheim | Neutral → Sell |
| 2022-08-12 | 開始されました | DA Davidson | Buy |
| 2022-08-02 | ダウングレード | Berenberg | Buy → Hold |
| 2022-08-02 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-07-28 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-28 | ダウングレード | Needham | Buy → Hold |
| 2022-07-06 | 繰り返されました | BofA Securities | Neutral |
| 2022-05-05 | ダウングレード | Argus | Buy → Hold |
| 2022-04-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-04-28 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-04-28 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-04-28 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-03 | アップグレード | Argus | Hold → Buy |
| 2022-02-23 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-23 | 繰り返されました | Craig Hallum | Hold |
| 2022-02-23 | 繰り返されました | Evercore ISI | In-line |
| 2022-02-23 | 繰り返されました | Goldman | Buy |
| 2022-02-23 | 繰り返されました | JP Morgan | Overweight |
| 2022-02-23 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | 繰り返されました | Needham | Buy |
| 2022-02-23 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-23 | 繰り返されました | Stifel | Hold |
| 2022-02-11 | 開始されました | Goldman | Buy |
| 2022-02-08 | 繰り返されました | Piper Sandler | Overweight |
| 2021-12-02 | 再開されました | Jefferies | Hold |
| 2021-11-22 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-10-28 | 繰り返されました | Barclays | Equal Weight |
| 2021-10-28 | 繰り返されました | BofA Securities | Neutral |
| 2021-10-28 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-10-28 | 繰り返されました | Citigroup | Buy |
| 2021-10-28 | 繰り返されました | Craig Hallum | Hold |
| 2021-10-28 | 繰り返されました | Needham | Buy |
| 2021-10-28 | 繰り返されました | Oppenheimer | Outperform |
| 2021-10-28 | 繰り返されました | Piper Sandler | Overweight |
| 2021-10-28 | 繰り返されました | UBS | Neutral |
| 2021-10-19 | 開始されました | Wells Fargo | Overweight |
| 2021-08-02 | ダウングレード | Argus | Buy → Hold |
| 2021-07-28 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-05-28 | 開始されました | Robert W. Baird | Neutral |
| 2021-04-15 | 開始されました | Needham | Buy |
| 2021-01-07 | 開始されました | BTIG Research | Buy |
| 2020-12-22 | 開始されました | Evercore ISI | In-line |
| 2020-12-07 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | 開始されました | Goldman | Neutral |
| 2020-11-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | 開始されました | DA Davidson | Buy |
| 2020-09-02 | アップグレード | Berenberg | Hold → Buy |
| 2020-08-17 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | 開始されました | Citigroup | Buy |
| 2020-07-13 | 開始されました | Argus | Buy |
| 2020-07-07 | 開始されました | Stephens | Overweight |
| 2020-04-30 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | 開始されました | SVB Leerink | Outperform |
| 2020-03-31 | ダウングレード | Berenberg | Buy → Hold |
| 2020-03-25 | ダウングレード | Craig Hallum | Buy → Hold |
| 2020-03-16 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | 開始されました | UBS | Neutral |
| 2020-01-09 | ダウングレード | BofA/Merrill | Buy → Neutral |
すべてを表示
Teladoc Health Inc (TDOC) 最新ニュース
Teladoc Health (TDOC) Surges 14% After Beating Q4 2025 Estimates - GuruFocus
Demystifying Teladoc Health: Insights From 8 Analyst Reviews - Benzinga
TDOC: BMO Capital Lowers Price Target, Maintains Market Perform Rating | TDOC Stock News - GuruFocus
Teladoc Health (NYSE:TDOC) Given New $6.00 Price Target at TD Cowen - MarketBeat
BMO Capital Markets Issues Pessimistic Forecast for Teladoc Health (NYSE:TDOC) Stock Price - MarketBeat
These Analysts Slash Their Forecasts On Teladoc Health After Q4 Results - Benzinga
BofA upgrades Teladoc stock rating on BetterHelp margin outlook By Investing.com - Investing.com Canada
Teladoc Health (NYSE:TDOC) Stock Rating Upgraded by Bank of America - MarketBeat
TDOC's Price Target Lowered by Piper Sandler Amid Overweight Rat - GuruFocus
Teladoc upgraded at BofA on BetterHelp prospects (TDOC:NYSE) - Seeking Alpha
Why Teladoc (TDOC) Stock Is Up Today - Finviz
Evercore ISI Group Maintains In-Line Rating for TDOC, Lowers Pri - GuruFocus
Wells Fargo Adjusts Price Target for TDOC, Maintains Equal-Weigh - GuruFocus
Teladoc Health (NYSE:TDOC) Earns Overweight Rating from Piper Sandler - MarketBeat
Teladoc Health Inc. Beats Expectations and Names New Board Members - StocksToTrade
Teladoc Health (TDOC): Analyst Maintains 'Hold' Rating, Lowers P - GuruFocus
Teladoc Health (NYSE:TDOC) Price Target Cut to $6.00 by Analysts at Wells Fargo & Company - MarketBeat
Stifel cuts Teladoc stock price target to $6 on revenue pressures - Investing.com Canada
Teladoc Health, Inc. SEC 10-K Report - TradingView
Teladoc Health (NYSE:TDOC) Shares Up 14.6% on Earnings Beat - MarketBeat
Stifel Nicolaus Cuts Teladoc Health (NYSE:TDOC) Price Target to $6.00 - MarketBeat
Here's What Key Metrics Tell Us About Teladoc (TDOC) Q4 Earnings - Yahoo Finance UK
Wells Fargo cuts Teladoc stock price target on flat growth outlook - Investing.com Canada
Teladoc Health (TDOC) Surpasses Q4 Expectations with Strong Earnings - GuruFocus
Teladoc Inc earnings beat by $0.04, revenue topped estimates - Investing.com Australia
Teladoc Health Inc (TDOC) Q4 2025 Earnings Call Highlights: Navi - GuruFocus
Teladoc Health hosts events in Orlando and Nashville to drive healthcare evolution - Traders Union
Teladoc Health (TDOC) Surpasses Q4 Expectations, Offers Mixed 20 - GuruFocus
TDOC: 2026 guidance projects flat revenue, margin gains, and strong BetterHelp insurance growth - TradingView
Earnings call transcript: Teladoc Inc beats Q4 2025 forecasts, stock rises - Investing.com
Teladoc Health (TDOC) Projects FY26 Revenue Growth - GuruFocus
Teladoc Health (TDOC) Projects Lower Q1 Revenue Than Expected - GuruFocus
Teladoc (NYSE:TDOC) Surprises With Q4 CY2025 Sales - Finviz
Teladoc Q4 results beat on both lines; 2026 guidance figures include consensus (TDOC:NYSE) - Seeking Alpha
Teladoc posts narrower-than-feared Q4 loss, revenue beat, but guidance disappoints - Investing.com UK
Teladoc: Q4 Earnings Snapshot - marketscreener.com
Teladoc Health (NYSE:TDOC) Releases Q1 2026 Earnings Guidance - MarketBeat
Teladoc Health (NYSE:TDOC) Announces Quarterly Earnings Results - MarketBeat
Teladoc Health (NYSE:TDOC) Updates FY 2026 Earnings Guidance - MarketBeat
Teladoc Health Reports Fourth Quarter and Full Year 2025 Results - Bluefield Daily Telegraph
Teladoc (TDOC) Pre-Earnings Options Activity Points to Significa - GuruFocus
Teladoc Q4 earnings: Can integrated care strength save profits? - MSN
Teladoc Health (TDOC) Faces Revenue Decline Amid Challenges - GuruFocus
Teladoc Health Q4 Preview: Here's what to expect - Seeking Alpha
Moving Averages: Is Teladoc Health Inc a stock for growth or value investorsJuly 2025 Earnings & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Women's Mental Wellness Market Next Big Thing | Major Giants Teladoc, AXA, Clue - openPR.com
Teladoc gains trusted finance insights with Oracle Fusion Data Intelligence - Oracle
Teladoc (TDOC) Q4 Earnings: What To Expect - Finviz
BofA and Goldman Cut Teladoc (TDOC) Price Targets - Finviz
After Hours: Teladoc Health (4LL.F XETRA) €4.15 +5.83% on 23 Feb 2026: watch upcoming earnings - Meyka
BofA and Goldman cut Teladoc (TDOC) price targets - MSN
Teladoc Health Inc (TDOC) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):